Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Blocking the Thrombin Receptor Promotes Repair of Demyelinated Lesions in the Adult Brain.

Yoon H, Choi CI, Triplet EM, Langley MR, Kleppe LS, Kim HN, Simon WL, Scarisbrick IA.

J Neurosci. 2020 Jan 7. pii: 2029-19. doi: 10.1523/JNEUROSCI.2029-19.2019. [Epub ahead of print]

PMID:
31911460
2.

Cell surface protein disulfide isomerase regulates natriuretic peptide generation of cyclic guanosine monophosphate.

Pan S, Chen HH, Correia C, Dai H, Witt TA, Kleppe LS, Burnett JC Jr, Simari RD.

PLoS One. 2014 Nov 24;9(11):e112986. doi: 10.1371/journal.pone.0112986. eCollection 2014.

3.

Characterization of a resident population of adventitial macrophage progenitor cells in postnatal vasculature.

Psaltis PJ, Puranik AS, Spoon DB, Chue CD, Hoffman SJ, Witt TA, Delacroix S, Kleppe LS, Mueske CS, Pan S, Gulati R, Simari RD.

Circ Res. 2014 Jul 18;115(3):364-75. doi: 10.1161/CIRCRESAHA.115.303299. Epub 2014 Jun 6.

PMID:
24906644
4.

Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus.

Holroyd EW, Delacroix S, Larsen K, Harbuzariu A, Psaltis PJ, Wang L, Pan S, White TA, Witt TA, Kleppe LS, Mueske CS, Mukhopadhyay D, Simari RD.

Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):704-11. doi: 10.1161/ATVBAHA.111.243733. Epub 2012 Jan 5.

5.

Identification of a monocyte-predisposed hierarchy of hematopoietic progenitor cells in the adventitia of postnatal murine aorta.

Psaltis PJ, Harbuzariu A, Delacroix S, Witt TA, Holroyd EW, Spoon DB, Hoffman SJ, Pan S, Kleppe LS, Mueske CS, Gulati R, Sandhu GS, Simari RD.

Circulation. 2012 Jan 31;125(4):592-603. doi: 10.1161/CIRCULATIONAHA.111.059360. Epub 2011 Dec 27.

6.

Tissue factor pathway inhibitor overexpression inhibits hypoxia-induced pulmonary hypertension.

White TA, Witt TA, Pan S, Mueske CS, Kleppe LS, Holroyd EW, Champion HC, Simari RD.

Am J Respir Cell Mol Biol. 2010 Jul;43(1):35-45. doi: 10.1165/rcmb.2009-0144OC. Epub 2009 Jul 31.

7.

Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide.

Pan S, Chen HH, Dickey DM, Boerrigter G, Lee C, Kleppe LS, Hall JL, Lerman A, Redfield MM, Potter LR, Burnett JC Jr, Simari RD.

Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11282-7. doi: 10.1073/pnas.0811851106. Epub 2009 Jun 18.

8.

Distribution of circulation-derived endothelial progenitors following systemic delivery.

Smits PA, Kleppe LS, Witt TA, Mueske CS, Vile RG, Simari RD.

Endothelium. 2007 Jan-Feb;14(1):1-5.

PMID:
17364891
9.

The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor in a murine model of arterial thrombosis.

Pan S, Kleppe LS, Witt TA, Mueske CS, Simari RD.

Thromb Haemost. 2004 Sep;92(3):495-502.

PMID:
15351845
10.

Modulation of the vascular response to injury by autologous blood-derived outgrowth endothelial cells.

Gulati R, Jevremovic D, Witt TA, Kleppe LS, Vile RG, Lerman A, Simari RD.

Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H512-7. Epub 2004 Apr 8.

11.

Autologous culture-modified mononuclear cells confer vascular protection after arterial injury.

Gulati R, Jevremovic D, Peterson TE, Witt TA, Kleppe LS, Mueske CS, Lerman A, Vile RG, Simari RD.

Circulation. 2003 Sep 23;108(12):1520-6. Epub 2003 Sep 2.

PMID:
12952850
12.

Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway.

Peterson TE, Guicciardi ME, Gulati R, Kleppe LS, Mueske CS, Mookadam M, Sowa G, Gores GJ, Sessa WC, Simari RD.

Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1521-7. Epub 2003 Jun 19.

PMID:
12816877
13.

Tissue factor pathway inhibitor deficiency enhances neointimal proliferation and formation in a murine model of vascular remodelling.

Singh R, Pan S, Mueske CS, Witt TA, Kleppe LS, Peterson TE, Caplice NM, Simari RD.

Thromb Haemost. 2003 Apr;89(4):747-51.

PMID:
12669131
14.

A direct mechanical method for accurate and efficient adenoviral vector delivery to tissues.

Khurana VG, Weiler DA, Witt TA, Smith LA, Kleppe LS, Parisi JE, Simari RD, O'Brien T, Russell SJ, Katusic ZS.

Gene Ther. 2003 Mar;10(5):443-52.

PMID:
12601399
15.

Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis.

Caplice NM, Panetta C, Peterson TE, Kleppe LS, Mueske CS, Kostner GM, Broze GJ Jr, Simari RD.

Blood. 2001 Nov 15;98(10):2980-7.

PMID:
11698280
16.

Role for tissue factor pathway in murine model of vascular remodeling.

Singh R, Pan S, Mueske CS, Witt T, Kleppe LS, Peterson TE, Slobodova A, Chang JY, Caplice NM, Simari RD.

Circ Res. 2001 Jul 6;89(1):71-6.

PMID:
11440980
17.

The regulation of caveolin expression and localization by serum and heparin in vascular smooth muscle cells.

Peterson TE, Kleppe LS, Caplice NM, Pan S, Mueske CS, Simari RD.

Biochem Biophys Res Commun. 1999 Nov 30;265(3):722-7.

PMID:
10600487
18.

Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors.

Caplice NM, Mueske CS, Kleppe LS, Peterson TE, Broze GJ Jr, Simari RD.

Circ Res. 1998 Dec 14-28;83(12):1264-70.

PMID:
9851943
19.

Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity.

Caplice NM, Mueske CS, Kleppe LS, Simari RD.

Circulation. 1998 Sep 15;98(11):1051-7.

PMID:
9736590

Supplemental Content

Loading ...
Support Center